• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
BDX 4.55% 10.5¢

BCAL DIAGNOSTICS LIMITED - Discussion

BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on... BCAL Diagnostics Limited is an Australia-based biotechnology company, which is focused on improving health outcomes for women. The Company’s principal activities include the development of a novel blood screening test to improve the early diagnosis and monitoring of breast cancer, including preparation for clinical trials. It developed a blood screening test to be used alongside breast cancer screening methods. The technology initially complements imaging technologies, such as the mammogram, while it further progresses the development of a monitoring and screening test suitable for women of all ages and backgrounds in any location. Its BCAL test is a lipid biomarker blood (Breast Cancer Associated Lipids test) test with the potential to be used for breast cancer prevention, screening, and monitoring. The Company has partnered with Precion Inc. to optimize protocols and procedures for the clinical studies required for regulatory approvals across several jurisdictions.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Bcal Diagnostics Limited

Forum Tag Subject View Poster Comments Created with Sketch. Views Created with Sketch. Likes Created with Sketch. Date Created with Sketch.
ASX News
(20min delay)
Last
10.5¢
Change
-0.005(4.55%)
Mkt cap ! $43.93M
Open High Low Value Volume
10.5¢ 10.5¢ 10.5¢ $44.92K 427.8K

Buyers (Bids)

No. Vol. Price($)
5 1039738 10.0¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 10525 1
View Market Depth
Last trade - 12.53pm 15/11/2024 (20 minute delay) ?
Last
10.5¢
  Change
-0.005 ( 0.00 %)
Open High Low Volume
10.5¢ 10.5¢ 10.5¢ 315691
Last updated 13.04pm 15/11/2024 ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.